Back
Varonis Systems 10K Form
Sell
46
VRNS
Varonis Systems
Last Price:
50.92
Seasonality Move:
19.01%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2024-05-07 | 10Q | VRNS/Varonis Systems Quarterly |
2023-10-31 | 10Q | VRNS/Varonis Systems Quarterly |
2023-08-01 | 10Q | VRNS/Varonis Systems Quarterly |
2023-05-02 | 10Q | VRNS/Varonis Systems Quarterly |
2022-11-01 | 10Q | VRNS/Varonis Systems Quarterly |
2022-08-02 | 10Q | VRNS/Varonis Systems Quarterly |
Receive VRNS News And Ratings
See the #1 stock for the next 7 days that we like better than VRNS
VRNS Financial Statistics
Sales & Book Value
Annual Sales: | $499.16M |
---|---|
Cash Flow: | $14.6M |
Price / Cash Flow: | 62.49 |
Annual Sales: | $3.81 |
Price / Book: | 13.36 |
Profitability
EPS (TTM): | -0.75000 |
---|---|
Net Income (TTM): | $-83.67M |
Gross Margin: | $427.41M |
Return on Equity: | -18.4% |
Return on Assets: | -7.22% |
Varonis Systems Earnings Forecast
Key Varonis Systems Financial Ratios
- The Gross Profit Margin over the past 14 years for VRNS is 85.63%.
- The Selling, General & Administrative Expenses for VRNS have been equal to 72.28% of Gross Profit Margin.
- The Research & Development expenses have been 36.83% of Revenue.
- The Interest Expense is -3.17% of Operating Income.
- The Net Earning history of VRNS is -20.22% of Total Revenues.
- Per Share Earnings over the last 14 years have been positive in 4 years.
Varonis Systems Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NASDAQ |
---|---|
Industry: | Software |
Sector: | Information Technology |
Current Symbol: | VRNS |
CUSIP: | 922280 |
Website: | varonis.com |
Debt
Debt-to-Equity Ratio: | 1.64 |
---|---|
Current Ratio: | 1.81 |
Quick Ratio: | 1.68 |
Price-to-Earnings
Trailing P/E Ratio: | 0 |
---|---|
Forward P/E Ratio: | 148.86 |
VRNS Technical Analysis vs Fundamental Analysis
Sell
46
Varonis Systems (VRNS)
is a Sell
Is Varonis Systems a Buy or a Sell?
-
Varonis Systems stock is rated a Sell
The current Varonis Systems [VRNS] share price is $50.89. The Score for VRNS is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.